Claritev Corporation (NYSE: CTEV) is a Healthcare company (Medical - Healthcare Information Services) with a market capitalization of $392M. The Maz Rating grades it against the other companies in its sector.
Claritev Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $22.95, Claritev Corporation trades at 0.4x sales, with an EV/EBITDA of 10.3. Over the last twelve months it generated about $1.0B of revenue and a net loss of $280M. It runs a gross margin of 33.8%, an operating margin of 5.8% and a net margin of -27.1%. It shows return on equity of 104.2%, return on invested capital of 1.0% and a free cash flow yield of -7.2%. On the balance sheet: a debt-to-equity ratio of -13.37 and a current ratio of 1.15. Over the past 52 weeks the share price ranged from $11.50 to $55.50, with a beta of 0.79.
Claritev Corporation does not currently pay a dividend.
6 Wall Street analyst ratings cover the stock: 5 Buy and 1 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.